Aspira Women's Health Inc. SEC filings AWHL

Aspira Women's Health Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 12, 2011. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 15, 2026 (material agreement, new debt). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
10-K Annual report Apr 1, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 14, 2025 Dec 31, 2024
10-K Annual report Mar 27, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 1, 2024 Dec 31, 2023
10-K Annual report Apr 1, 2024 Dec 31, 2023
10-K/A Amended annual report Oct 26, 2023 Dec 31, 2022
ARS Annual report to shareholders Apr 4, 2023 Dec 31, 2022
10-K Annual report Mar 30, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
10-K/A Amended annual report Apr 30, 2021 Dec 31, 2020
10-K Annual report Mar 31, 2021 Dec 31, 2020
10-K Annual report Apr 7, 2020 Dec 31, 2019
10-K/A Amended annual report Apr 29, 2019 Dec 31, 2018
10-K Annual report Mar 28, 2019 Dec 31, 2018
10-K/A Amended annual report Apr 30, 2018 Dec 31, 2017
10-K Annual report Mar 13, 2018 Dec 31, 2017
10-K Annual report Mar 31, 2017 Dec 31, 2016
10-K Annual report Mar 30, 2016 Dec 31, 2015
10-K Annual report Mar 31, 2015 Dec 31, 2014
10-K Annual report Mar 31, 2014 Dec 31, 2013
ARS Annual report to shareholders Mar 4, 2013 Dec 31, 2012
10-K Annual report Mar 1, 2013 Dec 31, 2012
ARS Annual report to shareholders Feb 1, 2013 Dec 31, 2011
10-K/A Amended annual report May 30, 2012 Dec 31, 2011
10-K/A Amended annual report Apr 27, 2012 Dec 31, 2011
10-K Annual report Mar 27, 2012 Dec 31, 2011

Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
AWHL (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Austin, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
926617
Former names
VERMILLION, INC. (until Jun 10, 2020); CIPHERGEN BIOSYSTEMS INC (until Aug 17, 2007)

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.